Close Menu

In an article in last week's Genome Biology, scientists used sys bio tools to study how some highly disordered proteins avoid degradation in order to carry out their function. Combining sequencing, gene expression, and proteomic information, they were able to see that not only do disordered proteins have a greater proportion of predicted ubiquitination sites, but also their transcripts have higher proportions of predicted miRNA target sites and higher mRNA decay rates.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.